Tag Archives: Soumit Roy

JonesTrading Initiates a Buy Rating on Chimerix (CMRX)

In a report released today, Soumit Roy from JonesTrading initiated coverage with a Buy rating on Chimerix (CMRX – Research Report) and a price target of $10.00. The company’s shares closed last Wednesday at $3.41. According to TipRanks.com, Roy is

Aeglea Biotherapeutics (AGLE) Receives a Buy from JonesTrading

JonesTrading analyst Soumit Roy reiterated a Buy rating on Aeglea Biotherapeutics (AGLE – Research Report) today and set a price target of $22.00. The company’s shares closed last Thursday at $7.84. According to TipRanks.com, Roy is a 5-star analyst with

Why Did JonesTrading Downgrade Verastem’s Stock?

JonesTrading analyst Soumit Roy downgraded Verastem (VSTM – Research Report) to Hold today. The company’s shares closed last Monday at $2.12. According to TipRanks.com, Roy is a 4-star analyst with an average return of 10.4% and a 37.4% success rate.

JonesTrading Keeps Their Buy Rating on Mirati Therapeutics (MRTX)

JonesTrading analyst Soumit Roy reiterated a Buy rating on Mirati Therapeutics (MRTX – Research Report) today and set a price target of $130.00. The company’s shares closed last Monday at $93.79. According to TipRanks.com, Roy is a 4-star analyst with

JonesTrading Sticks to Their Buy Rating for Surface Oncology (SURF)

In a report released today, Soumit Roy from JonesTrading reiterated a Buy rating on Surface Oncology (SURF – Research Report), with a price target of $12.00. The company’s shares closed last Thursday at $2.72. According to TipRanks.com, Roy is a

JonesTrading Thinks Aileron Therapeutics’ Stock is Going to Recover

JonesTrading analyst Soumit Roy initiated coverage with a Buy rating on Aileron Therapeutics (ALRN – Research Report) today and set a price target of $5.00. The company’s shares closed last Tuesday at $0.32, close to its 52-week low of $0.25.